Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |